Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna iito 600x60px

News > All

Total search results: 9872 | Ordered by Date (descending)
1 2 3 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
InflaRx N.V.. (2/14/19). "Press Release: Richard Brudnick to Join InflaRx Board of Directors". Jena. 2019-02-14
High-Tech Gründerfonds Management GmbH. (2/14/19). "Press Release: Plasmion’ SICRIT Sensor Technology Convinces Investors". 2019-02-14
Novartis AG. (2/13/19). "Press Release: Novartis Receives FDA Approval for Egaten for the Treatment of Fascioliasis, a Neglected Tropical Disease". Basel. 2019-02-13
Sanofi S.A.. (2/12/19). "Press Release: Sanofi Appoints Ameet Nathwani Chief Digital Officer". Paris. 2019-02-12
Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried. 2019-02-11
Spectro Analytical Instruments GmbH. (2/11/19). "Press Release: Spectro Introduces SpectroGreen ICP-OES Analyzer". 2019-02-11
Bruker Corporation. (2/11/19). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2018 Financial Results". Billerica, MA. 2019-02-11
Vita 34 AG. (2/8/19). "Press Release: Vita 34 Develops Cell Preparations as the Source Material for Immune Cell Therapies and Becomes Cell Bank". Leipzig. 2019-02-08
Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]". 2019-02-08
Sanofi S.A.. (2/7/19). "Press Release: Sanofi Delivers 2018 Business EPS Growth of 5.1% at CER". Paris. 2019-02-07
Lunaphore Technologies S.A.. (2/7/19). "Press Release: Lunaphore Launches Its First Product LabSat". Lausanne. 2019-02-07
Evotec AG. (2/7/19). "Press Release: Evotec Mourns Loss of Company Co-founder Prof. Manfred Eigen". Hamburg. 2019-02-07
HiberCell. (2/7/19). "Press Release: HiberCell Launches to Prevent Cancer Relapse and Metastasis with Novel Therapeutics. $60.75M Funding Round Led by ARCH Venture Partners with 6 Dimensions Capital". New York, NY. 2019-02-07
Evotec AG. (2/7/19). "Press Release: Evotec and Galapagos Enter into Collaboration in the Field of Fibrosis". Hamburg & Mechelen. 2019-02-07
4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. 2019-02-06
GlaxoSmithKline plc. (2/6/19). "Press Release: GSK Delivers Sales, Earnings and Cash Flow Growth in 2018". London. 2019-02-06
Merck KGaA. (2/6/19). "Press Release: Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline". Darmstadt. 2019-02-06
InflaRx N.V.. (2/6/19). "Press Release: InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. 2019-02-06
Andrew Alliance S.A.. (2/6/19). "Press Release: Andrew Alliance and Waters Corporation Partner to Provide Tailored Tools for LC-MS Research". 2019-02-06
MacroGenics, Inc.. (2/6/19). "Press Release: MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of Margetuximab". Rockville, MD. 2019-02-06
Roche. (2/6/19). "Press Release: Roche Joins the World Federation of Hemophilia Humanitarian Aid Program". Basel. 2019-02-06
Xencor, Inc.. (2/5/19). "Press Release: Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech". Monrovia, CA. 2019-02-05
Genedata AG. (2/5/19). "Press Release: Genedata Announces Bruker as a New Ready-to-Run Partner". Washington, DC. 2019-02-05
Genedata AG. (2/4/19). "Press Release: New Web-based Genedata Screener Showcases at SLAS2019". Washington, DC. 2019-02-04
Andrew Alliance S.A.. (2/4/19). "Press Release: Macherey-Nagel GmbH & Co. KG and Andrew Alliance Sign Co-Marketing Agreement". Geneva. 2019-02-04
Qiagen N.V.. (2/4/19). "Press Release: Qiagen Informatics Solutions Chosen to Support Genomics England’s Bold Five Million Genomes in Five Years Project". Hilden & London. 2019-02-04
Qiagen N.V.. (2/4/19). "Press Release: Qiagen Reports Results for Fourth Quarter and Full-year 2018". Venlo. 2019-02-04
Memo Therapeutics AG. (2/1/19). "Press Release: Memo Therapeutics Announces the Development of a Droplet Sorter Enabling Functional Antibody Screening in a High-Throughput Format". 2019-02-01
[iito] Business Intelligence. (2/1/19). "Press Release: [iito] Web Portals Surpass Half a Million Page Views per Month". Bremen. 2019-02-01
Bayer AG. (1/31/19). "Press Release: Bayer and Kyoto University Form Research Alliance to Discover New Treatment Approaches against Lung Diseases [Not intended for U.S. and UK Media]". Berlin. 2019-01-31
Apceth Biopharma GmbH. (1/31/19). "Press Release: Hitachi Chemical Co. Ltd. to Acquire Apceth Biopharma GmbH". Munich. 2019-01-31
Roche. (1/31/19). "Press Release: Roche Reports Very Strong Results in 2018. Group Sales Increase 7% at Constant Exchange Rates and in Swiss Francs". Basel. 2019-01-31
Symrise AG. (1/31/19). "Press Release: Symrise Strengthens Pet Food Activities and Expands US Footprint with Acquisition of ADF/IDF". 2019-01-31
Hitachi Chemical Co., Ltd.. (1/31/19). "Press Release: Notice Regarding the Stock Acquisition of Apceth Biopharma GmbH, a Contract Manufacturer of Regenerative Medicine Products". 2019-01-31
MorphoSys AG. (1/31/19). "Press Release: MorphoSys Announces Settlement in Patent Lawsuit with Janssen and Genmab". Planegg. 2019-01-31
Curetis N.V.. (1/30/19). "Press Release: Curetis’ Unyvero Application Cartridges Receive Regulatory Approvals in Malaysia and Thailand". Amsterdam & Holzgerlingen. 2019-01-30
Dewpoint Therapeutics. (1/30/19). "Press Release: Dewpoint Therapeutics Launches with $60 Million Series A to Advance Proprietary Platform for Drugging Condensates". Cambridge, MA. 2019-01-30
Orphazyme A/S. (1/30/19). "Press Release: Orphazyme Reports Positive Results from Full Data Set of Phase II/III Arimoclomol Tria in Niemann-Pick Disease Type C (NPC)". Copenhagen. 2019-01-30
Roche. (1/30/19). "Press Release: Roche to Discontinue Phase III CREAD 1 and 2 Clinical Studies of Crenezumab in Early Alzheimer’s Disease (AD) - other Company Programmes in AD Continue". Basel. 2019-01-30
Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Announces Strong Investor Demand and Expected Offer Price (Adhoc-News)". 2019-01-29
Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Sets Offer Price at 75 Euro per Share (Adhoc-News)". 2019-01-29
Genmab A/S. (1/26/19). "Press Release: Genmab Announces that the Patents Asserted against Darzalex in the United States Have Been Declared Invalid by Summary Judgment". Copenhagen. 2019-01-26
MorphoSys AG. (1/26/19). "Press Release: MorphoSys Announces That Its Patents Were Ruled Invalid in Patent Lawsuit Against Janssen and Genmab (Ad hoc)". Planegg. 2019-01-26
Boehringer Ingelheim. (1/24/19). "Press Release: Boehringer Ingelheim Partners with AMPATH to Scale Up Knowledge, Skills and Training for Healthcare Providers in Kenya". Ingelheim. 2019-01-24
Boehringer Ingelheim. (1/24/19). "Press Release: Boehringer Ingelheim Launches First Veterinary Vaccines Produced in China". Ingelheim. 2019-01-24
Merck KGaA. (1/24/19). "Press Release: Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors [Not intended for UK- or US-based media]". Darmstadt. 2019-01-24
BioNTech AG. (1/23/19). "Press Release: BioNTech to Acquire Antibody Generation Unit of MAB Discovery". Mainz & Munich. 2019-01-23
Sartorius AG. (1/23/19). "Press Release: Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE)". Göttingen & Glasgow. 2019-01-23
Merck KGaA. (1/23/19). "Press Release: Merck and Tencent Announce Collaboration on Intelligent Digital Healthcare Services in China". Chengdu. 2019-01-23
Clariant International AG. (1/23/19). "Press Release: Clariant Partners with ExxonMobil and Renewable Energy Group to Advance Cellulosic Biofuel Research". Muttenz, Irving, TX & Ames, IA. 2019-01-23
Marinomed Biotech AG. (1/23/19). "Press Release: Marinomed Resumes Offer Period of the IPO (Adhoc-News)". 2019-01-23
Grünenthal GmbH. (1/22/19). "Press Release: Fabian Raschke Appointed Chief Financial Officer (CFO)". Aachen. 2019-01-22
Scailyte AG. (1/22/19). "Press Release: Scailyte Raises CHF 2.75M in Seed Funding and Gains Swisscom Ventures and Zürcher Kantonalbank as Investors". 2019-01-22
Innovative Medicines Initiative (IMI). (1/22/19). "Press Release: Open Access Drug Development Tools Feature in New IMI Call for Proposals". Brussels. 2019-01-22
CRISPR Therapeutics AG. (1/22/19). "Press Release: CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies". Cambridge, MA, Boston, MA & Berlin. 2019-01-22
Kurma Partners. (1/21/19). "Press Release: Kurma Partners Sees Great Opportunities for Early-stage Biotech Investments in Germany and Launches Operations in Munich". Paris & Munich. 2019-01-21
Marinomed Biotech AG. (1/21/19). "Press Release: Partnership in China and EIB Financing [Not for US, AU, CA, JP or any other jurisdiction where prohibited by applicable law]". Vienna. 2019-01-21
Novo Holdings A/S. (1/21/19). "Press Release: Novo Holdings Announces New Investments by REPAIR Impact Fund. Four Investments Nade in First Year, Totalling €18 Million". Copenhagen. 2019-01-21
Alnylam Pharmaceuticals, Inc.. (1/21/19). "Press Release: Alnylam Pharmaceuticals and Medison Pharma Partner to Commercialize RNAi Therapeutics in Israel". Zug & Petach Tikva. 2019-01-21
Bruker Corporation. (1/18/19). "Press Release: Bruker Launches the G6 Leonardo for Oxygen, Nitrogen and Hydrogen (ONH) Analysis by Inert Gas Fusion". Delhi. 2019-01-18
Autifony Therapeutics Ltd.. (1/18/19). "Press Release: Autifony Therapeutics Achieves First Milestone in Agreement with Boehringer Ingelheim for a Novel Therapeutic Approach to a Range of CNS Disorders". Stevenage. 2019-01-18
Miltenyi Biotec GmbH. (1/17/19). "Press Release: Miltenyi Biotec Acquires Promising Non-harmful Imaging Process". Bergisch Gladbach. 2019-01-17
Boehringer Ingelheim. (1/17/19). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Expands Commercial Manufacturing Capacities". Shanghai. 2019-01-17
MorphoSys AG. (1/17/19). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Expanded Clinical Development of Guselkumab (Tremfya) into Ulcerative Colitis". Planegg. 2019-01-17
BioMed X GmbH. (1/17/19). "Press Release: BioMed X and Boehringer Ingelheim to Investigate Early Intervention in Psychiatric Diseases". Heidelberg. 2019-01-17
Agilent Technologies Inc.. (1/16/19). "Press Release: Mala Anand to Join Agilent's Board of Directors". Santa Clara, CA. 2019-01-16
Merck KGaA. (1/16/19). "Press Release: Merck Welcomes Ten New Startups to Its Innovation Center". Darmstadt. 2019-01-16
ADC Therapeutics S.A.. (1/16/19). "Press Release: ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors". Lausanne. 2019-01-16
Qiagen N.V.. (1/16/19). "Press Release: Qiagen Receives Approval for EGFR Test in Lung Cancer as Companion Diagnostic in Japan". Hilden & Tokyo. 2019-01-16
High-Tech Gründerfonds Management GmbH. (1/16/19). "Press Release: Series-A Investment for Munich-based Medical Technology Startup Mecuris". 2019-01-16
Tecan Group Ltd.. (1/15/19). "Press Release: Achim von Leoprechting Promoted to Become CEO of Tecan after Retirement of David Martyr". Männedorf. 2019-01-15
Bioharmony Therapeutics, Inc.. (1/15/19). "Press Release: Bioharmony Therapeutics and Boehringer Ingelheim Collaborate to Advance Bacteriophage Lysin Therapeutics for the Treatment of Multi-Drug Resistant Bacterial Infections". New York, NY. 2019-01-15
InterAx Biotech AG. (1/15/19). "Press Release: InterAx Biotech Closes Financing Round of CHF 3 Million and Appoints New Member of the Board". 2019-01-15
Qiagen N.V.. (1/14/19). "Press Release: Qiagen’s QuantiFERON-TB Gold Plus Gains Approval in Canada". Germantown, MD & Hilden. 2019-01-14
Bioké (Cell Signaling Technology Europe B.V.). (1/14/19). "Press Release: Bioké and OLS Omni Life Science Announce a Distribution Agreement for the BeNeLux Countries". Leiden. 2019-01-14
Merck KGaA [Merck Millipore]. (1/14/19). "Press Release: Merck and Roche Renew Global Distribution Agreement". 2019-01-14
[iito] Business Intelligence. (1/11/19). "Press Release: [iito] Discontinues Life-Sciences-UK.com and Life-Sciences-France.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. 2019-01-11
BC Platforms. (1/9/19). "Press Release: BC Platforms and MedEngine Announce a Strategic Partnership to Launch New Models for Global Medical Data Science Services". 2019-01-09
Selexis S.A.. (1/9/19). "Press Release: Selexis Expands Strategic Immuno-Oncology Alliance with Agenus". Geneva. 2019-01-09
Sirion Biotech GmbH. (1/9/19). "Press Release: Sirion Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System". Munich. 2019-01-09
c-LEcta GmbH. (1/9/19). "Press Release: c-LEcta Announces Two Long-term Industry Collaborations". 2019-01-09
Curetis N.V.. (1/8/19). "Press Release: Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test". Vienna, Amsterdam & Holzgerlingen. 2019-01-08
Immunic AG. (1/7/19). "Press Release: Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company". San Diego, CA & Planegg-Martinsried. 2019-01-07
Sanofi S.A.. (1/7/19). "Press Release: Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs". Paris & Tarrytown, NY. 2019-01-07
Qiagen N.V.. (1/7/19). "Press Release: Qiagen Acquires N-of-One, Expanding Its Clinical Bioinformatics Capabilities in Molecular Oncology Decision Support". Redwood City, CA & Hilden. 2019-01-07
Qiagen N.V.. (1/7/19). "Press Release: Qiagen Unveils Plans for Next-generation Digital PCR Systems". Hilden & Germantown, MD. 2019-01-07
Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Raises US$26 Million in Series B Financing Round to Accelerate Scaling as the Leading AI Drug Discovery Company". 2019-01-07
Eli Lilly and Company. (1/7/19). "Press Release: Lilly Announces Agreement to Acquire Loxo Oncology". Indianapolis, IN & Stamford, CT. 2019-01-07
Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Initiates Sixth AI Drug Discovery Partnership". 2019-01-07
Valneva S.E.. (1/7/19). "Press Release: Valneva Announces Its Intention to Delist from the Vienna Stock Exchange. Trading Will Be Centralized on Euronext Paris". Saint-Herblain. 2019-01-07
Valneva S.E.. (1/7/19). "Press Release: Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate". Saint-Herblain. 2019-01-07
Evotec AG. (1/7/19). "Press Release: Evotec Invests in Financing Round of Exscientia". Hamburg. 2019-01-07
Xencor, Inc.. (1/7/19). "Press Release: Xencor Regains ex-U.S. Commercial Rights to XmAb®13676, CD20 x CD3 Bispecific Antibody". Monrovia, CA. 2019-01-07
F2G Ltd.. (1/7/19). "Press Release: F2G Expands Investor Syndicate and Progresses Phase IIb Study for Novel Antifungal". Manchester. 2019-01-07
BioMed X GmbH. (1/7/19). "Press Release: Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology". Heidelberg. 2019-01-07
Boehringer Ingelheim. (1/4/19). "Press Release: Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna". Ingelheim & Cambridge, MA. 2019-01-04
Oculis S.A.. (1/4/19). "Press Release: Oculis Raises CHF15.5 Million in an Extension of Its Series B Financing Round – Total Raised CHF35.5 Million". Lausanne. 2019-01-04
BioNTech AG. (1/4/19). "Press Release: BioNTech Announces Corporate Form Transition from AG to SE; Welcomes Ryan Richardson as Senior Vice President Corporate Development and Strategy and Appoints Dr. Ulrich Wandschneider as Member of Supervisory Board". 2019-01-04
CRISPR Therapeutics AG. (1/4/19). "Press Release: CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease". Zug, Cambridge, MA & Boston, MA. 2019-01-04
Galapagos N.V.. (1/4/19). "Press Release: Fibrocor and Galapagos Sign Partnership in Fibrosis". Mechelen. 2019-01-04
1 2 3 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria iito 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px

» top